Clinical Trial Update: A Randomized Controlled Trial of Cognitive Remediation and D-cycloserine for Individuals With Bipolar Disorder [Phase 3]

View source ↗

Summary

Phase 3 randomized trial evaluating cognitive remediation with D-cycloserine for individuals with bipolar disorder completed, with results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder

Drugs mentioned

• D-cycloserine (D-cycloserine)
• cognitive remediation (cognitive remediation)

Snippet

Sponsor: University of Arizona | Conditions: Bipolar Disorder | Phase 3 | Status: COMPLETED | Results posted: 2020-06-04